These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2146913)

  • 1. Effect of intravenous streptokinase on early mortality in patients with suspected acute myocardial infarction. A meta-analysis by anatomic location of infarction .
    Midgette AS; O'Connor GT; Baron JA; Bell J
    Ann Intern Med; 1990 Dec; 113(12):961-8. PubMed ID: 2146913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction trials.
    Cerqueira MD; Maynard C; Ritchie JL; Davis KB; Kennedy JW
    J Am Coll Cardiol; 1992 Dec; 20(7):1452-9. PubMed ID: 1452917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction.
    Midgette AS; Wong JB; Beshansky JR; Porath A; Fleming C; Pauker SG
    Med Decis Making; 1994; 14(2):108-17. PubMed ID: 8028463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptokinase for the treatment of acute myocardial infarction: a brief review of randomized trials.
    Kennedy JW
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):28B-32B. PubMed ID: 3312370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
    Baigent C; Collins R; Appleby P; Parish S; Sleight P; Peto R
    BMJ; 1998 May; 316(7141):1337-43. PubMed ID: 9563981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.
    I.S.A.M. Study Group
    N Engl J Med; 1986 Jun; 314(23):1465-71. PubMed ID: 2871492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous thrombolysis in acute myocardial infarct].
    Schröder R
    Z Kardiol; 1986; 75 Suppl 5():93-100. PubMed ID: 3825231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous streptokinase in acute myocardial infarction (I.S.A.M.) trial: serial evaluation of left ventricular function up to 3 years after infarction estimated by radionuclide ventriculography. I.S.A.M. Study Group.
    Voth E; Tebbe U; Schicha H; Neuhaus KL; Schröder R
    J Am Coll Cardiol; 1991 Dec; 18(7):1610-6. PubMed ID: 1960304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.
    Kennedy JW; Martin GV; Davis KB; Maynard C; Stadius M; Sheehan FH; Ritchie JL
    Circulation; 1988 Feb; 77(2):345-52. PubMed ID: 3276409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.
    Goa KL; Henwood JM; Stolz JF; Langley MS; Clissold SP
    Drugs; 1990 May; 39(5):693-719. PubMed ID: 2191849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction.
    de Boer MJ; Hoorntje JC; Ottervanger JP; Reiffers S; Suryapranata H; Zijlstra F
    J Am Coll Cardiol; 1994 Apr; 23(5):1004-8. PubMed ID: 8144761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity.
    Schröder R; Neuhaus KL; Leizorovicz A; Linderer T; Tebbe U
    J Am Coll Cardiol; 1987 Jan; 9(1):197-203. PubMed ID: 3540072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.
    Battershill PE; Benfield P; Goa KL
    Drugs Aging; 1994 Jan; 4(1):63-86. PubMed ID: 8130384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous streptokinase in acute myocardial infarction (I.S.A.M.): assessment of left ventricular function 1 and 7 months after infarction by radionuclide ventriculography.
    Voth E; Tebbe U; Schicha H; Neumann P; Schröder R; Neuhaus KL; Emrich D
    Eur Heart J; 1990 Oct; 11(10):885-96. PubMed ID: 2265640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular function and infarct size: the Western Washington Intravenous Streptokinase in Myocardial Infarction Trial.
    Ritchie JL; Cerqueira M; Maynard C; Davis K; Kennedy JW
    J Am Coll Cardiol; 1988 Apr; 11(4):689-97. PubMed ID: 3280640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function.
    Bassand JP; Machecourt J; Cassagnes J; Anguenot T; Lusson R; Borel E; Peycelon P; Wolf E; Ducellier D
    J Am Coll Cardiol; 1989 Apr; 13(5):988-97. PubMed ID: 2647817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
    Lancet; 1988 Aug; 2(8607):349-60. PubMed ID: 2899772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of intravenous streptokinase in evolving acute myocardial infarction.
    Olson HG; Butman SM; Piters KM; Gardin JM; Lyons KP; Jones L; Chilazi G; Kumar KL; Colombo A
    Am Heart J; 1986 Jun; 111(6):1021-9. PubMed ID: 3521245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis in acute myocardial infarction: analysis of studies comparing accelerated t-PA and streptokinase.
    Smith BJ
    J Accid Emerg Med; 1999 Nov; 16(6):407-11. PubMed ID: 10572811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
    J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):3A-13A. PubMed ID: 2903874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.